Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 80
- Registration Number
- NCT06129175
- Locations
- 🇲🇾
Hospital Canselor Tuanku Muhriz UKM, Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia
Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury
Phase 2
Completed
- Conditions
- Osteoarthritis, Knee
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 28
- Registration Number
- NCT05016011
- Locations
- 🇲🇾
Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia
UCMSCs as Front-line Approach of Treatment for Patients With aGVHD
Phase 1
Active, not recruiting
- Conditions
- Acute-graft-versus-host Disease
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Cytopeutics Sdn. Bhd.
- Target Recruit Count
- 26
- Registration Number
- NCT03847844
- Locations
- 🇲🇾
Hospital Ampang, Ampang, Selangor, Malaysia
News
No news found